We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Ark Ther Grp | LSE:AKT | London | Ordinary Share | GB00BSZLMS59 | ORD 10P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 63.25 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 63.25 | GBX |
ARK Therapeutics (AKT) Share Charts1 Year ARK Therapeutics Chart |
|
1 Month ARK Therapeutics Chart |
Intraday ARK Therapeutics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 14/3/2015 | 16:32 | ARK THERAPEUTICS (AKT): CHART AND DISCUSSION THREAD (moderated) | 3,079 |
| 04/8/2014 | 15:10 | Any Views on Ark Therapeutics | 64 |
| 21/1/2013 | 11:07 | Ark Therapeutics with Charts & News | 2 |
| 08/7/2009 | 10:04 | Ark Therapeutics Charts | 511 |
| 11/1/2007 | 11:34 | ARC THERAPEUTICS (AKT): No. 1 CHART AND DISCUSSION THREAD (Moderated) | 3 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 14/3/2015 16:32 by hedgehog 100 Please note the thread for PVG created by pet lover on Tuesday of this week (10th. March):"DOG AND CAT OWNERS (PVG)" PVG currently 63.5p: a very nice premium to the 10.1p placing price!! |
Posted at 01/3/2015 16:36 by hedgehog 100 EJ,The directors here do seem to be very good at looking after themselves. They allowed themselves to invest in the placing at 10.1p, a discount of over 80% to the suspended share price consolidation-adjust Normal retail shareholders did not have that opportunity. And after the first day of trading back from suspension on Friday, the share price is now at 28.5p. And it was announced late in Friday afternoon trading that they have granted two of themselves options at 10.1p: 27/02/2015 16:07 UKREG Ark Therapeutics Group PLC Board Changes and Directors' Dealings London, UK, 27 February 2015 (LSE: AKT): The Company announces that it has today issued options to subscribe for new ordinary shares of 10 pence each in its capital, including awards to the following Directors: Name Role Number of options Exercise price per share --------------- -------------------- -------------------- Dominic Tonner Director (Chief 279,035 10.1 pence Executive Officer) --------------- -------------------- -------------------- Daniel Smith Director (Chief 209,277 10.1 pence Financial Officer) --------------- -------------------- -------------------- Each of the above options was granted pursuant to the 2014 Ark Therapeutics Group plc Enterprise Management Incentive Share Option Plan. As outlined in the Circular issued to Shareholders on 21 November 2014 (the "Circular") and the Prospectus published on 26 February 2015 (the "Prospectus"), the options were granted at an exercise price equal to the Subscription Price (as defined in the Circular and the Prospectus) of 10.1 pence, and will vest in full on the later of the first anniversary of the date of grant and the date that the market price of an ordinary share is at least twice the Subscription Price, and has been for a continuous period for 15 days. No consideration was paid for the grant of options. ... " |
Posted at 28/1/2015 17:14 by hedgehog 100 28/01/2015 09:29 UKREG Ark Therapeutics Group PLC Sale and Purchase Agreement Signed"Sale and Purchase Agreement Signed London, UK, 28 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, as foreshadowed in the Company's announcement and in its circular to shareholders, in each case dated 21 November 2014, it has entered into a share sale and purchase agreement with Rajan Uppal, Dominic Tonner and Berkeley Burke Trustee Company Limited to acquire 75.8% of the issued share capital of Premier Veterinary Group Limited ("PVG"). The aggregate consideration payable to all PVG shareholders is GBP3,731.18 in cash. The sellers have invoked the drag-along provisions contained in PVG's articles of association to enable the Company to acquire the entire issued share capital of PVG. Completion of the acquisition is scheduled to occur on 5 February 2015. The Company's shares will remain suspended until further notice but, as set out in the circular of 21 November 2014, it is the intention of the Company to publish a prospectus and to seek readmission of the Company's shares on the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. A further announcement will be made in due course." Though completion of the acquisition is due next week (Thursday), they don't say that the prospectus will be published then, and until that happens the suspension can't be lifted. As AKT is main-listed rather than AIM-listed, there is no time-limit for the suspension period (AIM has a 6-month limit). |
Posted at 21/1/2015 16:21 by hedgehog 100 On or around today:21/11/2014 17:48 UKREG Ark Therapeutics Group PLC Posting of Circular "10. Expected timetable of principal events Time and/or date ... Date upon which cancellation of the 14 January 2015 premium listing category will become effective Expected date of completion of the on or around 20 January Acquisition 2015 Expected date of publication of the on or around 21 January Prospectus 2015 ... The transfer from the official list has gone ahead, so I would expect further news imminently: 15/01/2015 07:00 UKREG Ark Therapeutics Group PLC Transfer of listing category on the Official List "London, UK, 15 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, following the passing of the relevant resolution by its shareholders at the Company's General Meeting on 11 December 2014, the Company's listing category will be transferred from "premium listing (commercial company)" to "standard listing" as of 8.00 am today. The Company's ordinary shares will remain suspended pending the publication of a prospectus in relation to the proposed acquisition of Premier Veterinary Group Limited, which constitutes a reverse takeover." |
Posted at 25/11/2014 21:27 by yorkiemike My understanding from the circular is that the consolidation factor is 100:1 not 10:1, so 100 existing shares = 1 new share (plus a deferred share which has no value). Therefore the subscription price for the directors equates to 0.101p in old money (i.e. about 20% of the pre-suspended price). Of course we don't know what the new shares will trade at if the proposal proceeds. If it is around the 10.1p subscription price then this is considerably lower than before the suspension, if more then a (substantial?) paper profit for the subscribing directors. Happy to be corrected if the foregoing is not right, and in any event stellar growth is most welcomed! |
Posted at 25/11/2014 18:13 by hedgehog 100 mypension 21 Nov'14 - 19:14 - 3035 of 3038 0 0"To me this seems very disappointment. After months the best the directors can come up with is 15% of a loss making business with debt of over two million at 12% interest. In addition 10,000 shares will become 1000. Maybe I have read the runs wrongly" Mypension, 15% of the enlarged equity is a decent share: I wouldn't think that the average share of the enlarged equity for a shell post RTO (reverse takeover)is more than 20%. And it can be far less than 15%. The consolidation won't actually affect the value of your shares: you'll simply have far fewer with each one worth proportionally as much more (other things being equal). Joeblogg2, Both bosses are putting in relatively large sums. But at a price that appears to be at a steep discount. 21/11/2014 17:48 UKREG Ark Therapeutics Group PLC Posting of Circular " ...3. Subscription for New Ordinary Shares Conditional upon Admission, BFSL and a small number of other investors have agreed to subscribe in aggregate for GBP1.2 million of Subscription Shares at a subscription price of 10.1 pence per Subscription Share. BFSL has requested that in order to agree to the Revised BFSL Loan Arrangements, Iain Ross, Chairman of Ark and the CEO of PVG participate in the Subscription as to GBP70,456.49 and GBP267,734.54 respectively. The monies received from the Subscription will be primarily used as working capital in the Enlarged Group's business and, as a result of this investment, Ark Shareholders will own 15 per cent. of the Ordinary Shares at Admission. Following the Subscription of 11,859,007 Subscription Shares (following the Consolidation and Subdivision), the Enlarged Group will have 13,951,773 Ordinary Shares in issue. ... " There's not much detail on PVG yet, but it's fast-growing, has substantial revenue of £7.5M. p.a., and is the second biggest buying group in its sector: "Mr Tonner, aged 57, joined PVG's board as CEO in July 2007. Since that time revenues have increased from GBP2 million to GBP7.5 million per annum, PVG has completed six acquisitions and integrated the activities successfully, launched a new business, Premier Veterinary Alliance, to become the second biggest buying group in the sector and is now transacting business in Republic of Ireland and the Nordic region as well as the UK." Ten Bag Man may be on holiday. |
Posted at 03/11/2014 12:05 by ten bag man Significant minority:From the WWW. "A minority is anything below 50% of a group. An insignificant minority will be a minority so small it doesn't really matter, while a significant minority will be something like 30% of a group. Clearly not the majority but big enough to be important for whatever purpose you're using it for." 30% sounds about right to me. My sums are based on this 30%(it could be higher or lower than 30%, time will no doubt tell)! If,(and it's a big if) this is in the ball park then here are some of my ideas. AKT shares stopped trading on March 28th 2014 @0.524p with a market cap of £1.2M Just for that value to stay the same of the first day of dealing the new company would have to have a market cap of around £4M Anything under £4M and old AKT shareholders will be making a loss (Based on the share price of 28th March 2014. So here we go. Market cap on first day of dealing. £4M break even. Then each extra Million pounds of market cap should I think give ARK shareholders and extra 30% on top of the £1.2M market cap on March 28th 2014. Thus: Each extra million of market cap gives AKT shareholders an extra £300,000 If the market cap on the first day of dealing was £14M AKT shareholders should be better off to the tune of £3M pounds. The share price would then be up 250%. |
Posted at 03/11/2014 08:39 by ten bag man AKT shares traded at 0.345P at the start of 2014.The directors paid ten times that amount for stock,so just to get their cash back they require a massive jump in the share price. (10 x) The only way to do that,(in my view)is to do an RTO. The RNS OF THE 28th of March 2014 tells shareholders the plan is to pick up a lump of the new companies shares in exchange for the FULL PREMIUM listing AKT has. That in itself is pointing to an instant gain for AKT shareholders. In effect part of the new company is to be given to us.!(if the RTO goes through) On top of this we will then be shareholders in the NEW company. That new company would have wanted to come to the London Stock Market for a reason. |
Posted at 03/11/2014 07:20 by ten bag man In the case of AKT.It is PREMIUM listed on the London Stock Exchange. Might want to look that up.! Note also the track record of the directors and the funding for over £250M they have bought to the market. Then take a look at the large shareholders,heaps of top city names inc Standard Life. AKT has stated for the last 18 months that it intends to do an RTO or hand back the cash in the company to shareholders. |
Posted at 24/3/2014 07:42 by tara7 FOUND THIS ON THE WEB:Well worth a read. AKT is fully listed [not on AIM] Cash Shells and Standard Listings 29/10/2012 Cash shells or SPACs (special purpose acquisition companies) are purpose-built vehicles with a stock market quote and a board of directors, but no active business and no assets other than a strong management (or advisory) team with specific sector expertise and the funds raised from financial backers (which will typically include management). The structure gives managers a ready-made stock market listing, a cash war chest and an acquisition currency at a time when, owing to global financial circumstances, the cost of financing is high and transactions are difficult to execute. The trend Cash shells were extremely popular on the AIM market seven years ago, arriving in such numbers that the LSE was forced to tighten the rules to safeguard the market's reputation. In March 2005 alone, 31 cash shells rushed to list to beat the introduction of the rule changes the following month, which stipulated that a cash shell must raise a minimum of £3 million, a figure deemed high enough to require at least some institutional interest. Other rule changes included tightening up the stated investing policy and a requirement to seek shareholders' consent annually to the continuance of the policy should it not be substantially implemented within 18 months of listing. The last couple of years have seen a number of cash shells not only returning to AIM, but, for the first time, obtaining admission to the Official List of the United Kingdom Listing Authority (UKLA) by way of a Standard listing. The timing of the appearance of these cash shells is a function of the regulatory environment of these markets and the volatile nature of the present economic climate. The cash shell structure is designed to take advantage of any dislocation in the market to acquire assets at favourable prices. When asset valuations start to rise, the opportunity for these acquisition vehicles could well disappear. The regulatory environment for Standard listed cash shells Access to the Premium listing segment of the Official List, whereby the issuer is subject to onerous eligibility and continuing obligation requirements and is potentially eligible for inclusion in the FTSE indices, is not possible for a cash shell; there are a number of entry requirements that a shell company simply would not be able to satisfy, which do not apply to Standard listing or to AIM applicants. In particular, a Premium listing applicant is required to have unqualified, consolidated, independently audited accounts covering a three-year period; a revenue earnings record in respect of at least 75 per cent of its business for a three year period; and a history of control over the majority of its assets for at least a three-year period. AIM cash shells are more heavily regulated than those with a Standard listing. In the last two years, management teams and their financial backers have increasingly been making a virtue of the minimal regulatory requirements applicable to cash shells with a Standard listing while raising very significant amounts of money on IPO. The key factor, as had been made explicit in the listing documents, was that a Standard listed issuer was not required to obtain shareholder approval for the acquisition of a target. While a Standard listing applicant must prepare a prospectus that is approved by the UKLA, it otherwise benefits from the relaxation of a number of rules that are applicable to Premium listed and/or AIM companies. Currently under the UKLA's Listing Rules, a Standard listed cash shell is not: required to appoint a financial adviser or sponsor on IPO or on a continuing basis (an AIM company is required to appoint a "nominated adviser" (or "nomad") at all times); subject to the "Listing Principles" set out in the UKLA Listing Rules; subject to any minimum fund raising requirement (other than to have a market capitalisation of £700,000 as set out in the UKLA Listing Rules applicable to all Official List companies); required to set out a formal investing policy or to implement it within any particular time frame (it follows that a change in investing policy is not subject to shareholder approval, nor is its ongoing validation in the event of failure to implement it within a stated period); required to seek shareholder approval for significant transactions (including transactions which would be categorised as a reverse takeover or a fundamental disposal of business); subject to the restrictions on share dealing (by the issuer or management); subject to restrictions as to the price and nature of share issuances or buy backs (although a Standard listed issuer must publish a prospectus if it issues, over a 12-month period, further securities that represent 10% or more of the securities of a class already admitted to trading); required to adhere to certain specific ongoing disclosure requirements (other than the general obligation to disclose price-sensitive information); required to seek shareholder or sponsor approval for related party transactions (a nomad must confirm to an AIM listed issuer that such a transaction is fair and reasonable insofar as the shareholders are concerned and certain prescribed details of the transaction must be notified to the market); required to offer new shares for cash on a pre-emptive basis to shareholders (indeed, typically any statutory pre-emption rights are disapplied prior to the IPO in connection with any shares to be issued to finance an acquisition); and required to comply with any corporate governance codes (although certain disclosures as to internal control and risk management procedures must be made in the issuer's annual report). In practice, issuers tend to voluntarily commit to certain standards or restrictions in relation to some of the above points, although the UKLA has no power to police compliance with such commitments. Notable transactions involving Standard listed cash shells Horizon Acquisition Company plc raised £417.7 million on its IPO and Standard listing in February 2010. Horizon achieved its investment goal by acquiring APR Energy, a Florida-based temporary power provider, in June 2011 for £527 million (£221 million in cash and £306 million in Horizon shares). The group retains its Standard listing. In June 2010 came the IPO and Standard listing of Nat Rothschild's Vallar plc, raising £687 million to fund acquisitions in the metals and mining industry. June 2011 saw the acquisition by Vallar of PT Bumi Resources Minerals Tbk, an international mining company, and a reorganisation resulting in the introduction of Bumi plc as the new Premium listed parent company. The acquisition price represented a total consideration of £1.27 billion. Marwyn Management Partners plc obtained a Standard listing in January 2011, raising a relatively modest £6 million. In August 2011, Marwyn acquired AIM-listed Praesepe plc, a gaming company, having raised approximately £40 million to complete the acquisition. Marwyn's investment objective is to acquire controlling and non-controlling interests in public and private companies, appointing operational managers with a "buy and build" strategy. The IPO in February 2011 of Justice Holdings Limited launched by, among others, Nicolas Berggruen, the billionaire backer of hedge fund GLG and Pearl Insurance, raised £900 million. Justice Holdings announced in April 2012 an investment of US$1.4 billion for 29% of Burger King. As part of the transaction, Justice merged with the new Burger King holding company, de-listed from the London Stock Exchange and re-listed on the New York Stock Exchange. Vallares plc, the second of Nat Rothchild's vehicles, raised £1.35 billion in June 2011 with a focus on oil and gas assets. In September 2011, Vallares announced the acquisition of Genel Energy International for US$2.1 billion. The enlarged group retains its Standard listing. Practical considerations and recent developments These listings, together with the record of successfully completed acquisitions, represent some of the most significant recent transactions in the London market and clearly show that the cash shell concept, particularly by way of Standard listing, remains compelling in current market conditions. A management team or group of investors thinking of establishing a London-listed cash shell for investment purposes and debating whether to opt for an AIM or Standard listing, should consider the following, in addition to the points referred to above: whilst there are a number of advantages of the Standard listing regime over AIM, the involvement of the UKLA in establishing eligibility for listings and approving the prospectus could lead to a longer IPO timetable compared to an AIM listing, where such matters are dealt with by the nomad; having considered the feedback from its consultation paper (CP12/2) issued in January 2012, in October 2012 the UKLA adopted the proposals to update the reverse takeover regime as applicable to Premium and Standard listed issuers. Under the Technical Note issued by the UKLA previously in force, transactions by Standard listed shells were treated as reverse takeovers in certain respects, namely (i) on completion of an acquisition, the company's shares would have been cancelled and the enlarged group would have had to re-apply for a listing on the back of a new prospectus; and (ii) listing may have been suspended pending publication of a new prospectus if there was insufficient information in the market on the target at the time of the announcement. The rule changes do not require that a Standard listed company seek shareholder approval for a reverse takeover. The revised Listing Rules have sought to reduce the information requirements that need to be met, after announcement of a transaction, in order for a suspension to be avoided, for Premium and Standard listed companies alike, and provide that if the company is acquiring another Premium or Standard listed entity and can establish eligibility for a continued listing in respect of the enlarged group, cancellation and re-admission (which would need a UKLA-approved prospectus to be prepared and published) can be avoided; whilst the minimum market capitalisation on listing of a Standard listed shell could, under the Listing Rules, be £700,000 the UKLA may query whether an issuer can properly carry out its investment policy with such a small amount of working capital. However, if a small shell listing is envisaged, this figure could still be significantly lower than the £3 million required on AIM; the founder incentive structures for the large Standard listings mentioned above have typically been complex, involving a mixture of straight equity and convertible securities, giving the founders an incentive based both on making an acquisition and the longer-term performance of the enlarged group. Further, management of the company and deal selection and execution are often outsourced, under an advisory agreement, to an unregistered advisory entity owned and operated by the founders. The founders have tended to invest a significant proportion of the IPO funding from their own resources. Note that the revised listing rules adopted in October 2012 as a result of the consultation exercise following CP12/2, make the principals of the advisory firm to a Standard listed cash shell (a so-called "externally managed company") responsible for any prospectus issued by the company and subject to rules on disclosure of share dealings. AIM cash shell listings, perhaps reflecting their smaller size, have tended to utilise simpler share, board and incentive arrangements. There is no reason why the AIM style is not equally appropriate for a Standard cash shell listing; as the above example transactions show, there are a variety of potential alternatives in respect of the continued listing of the enlarged group following completion of an acquisition. As stated above, the listing on the Standard segment would (unless the target is a Premium or Standard listed company) be cancelled on completion of a reverse takeover, and it would be possible to list the enlarged group on AIM instead. Otherwise, cancellation of a company's Standard listing at the company's request does not require shareholder approval; the requirement for a Standard listed company to prepare a prospectus if it wishes to issue 10% or more of its shares is not, in practice, likely to create extra work, expense or delay as the cash shell is likely to only issue new shares in connection with an acquisition, which would in any event require the production of a prospectus, or AIM admission document, for the enlarged group; it should be noted that the flexibility to make major disposals without seeking shareholder approval is a significant feature of the Standard listing regime, and may be of benefit to the company as its business grows over time. Recently, HMV Group sought shareholder approval to move from a Premium listing to a Standard listing (rather than AIM) explicitly to benefit from this flexibility in the context of the company's strategic review process. The listing category transfer was approved by 99.32% of the votes cast at the EGM; and it should be noted that the requirements for the inclusion and content of a competent person's report (CPR) in the prospectus for a Standard listing may be more flexible than those applicable to an AIM admission document. In relation to a Standard listing, the rules governing prospectuses specify content requirements that are recommended rather than compulsory (in particular, there is no compulsory requirement for a valuation of reserves and resources), provide that a site visit is not compulsory (being a matter of professional judgment for the competent person acting in accordance with the approved mineral codes), and establish that it may be possible to avoid the preparation of a CPR altogether by passporting a previously prepared CPR and/or annual market updates of reserves and resources on an overseas market or trading facility. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
